Detection of 5 Kinds of Genes Related to Plasmid-Mediated Quinolone Resistance in Four Species of Nonfermenting Bacteria with 2 Drug Resistant Phenotypes

Ming, De-Song; Chen, Qing-Qing; Chen, Xiao-Ting

doi:https://doi.org/10.1155/2020/3948719

Canadian Journal of Infectious Diseases and Medical Microbiology

On this page

Abstract Introduction Materials and Methods Results Discussion Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2020 | Article ID 3948719 | https://doi.org/10.1155/2020/3948719

Detection of 5 Kinds of Genes Related to Plasmid-Mediated Quinolone Resistance in Four Species of Nonfermenting Bacteria with 2 Drug Resistant Phenotypes

De-Song Ming,¹Qing-Qing Chen,¹and Xiao-Ting Chen¹

Academic Editor: Julia Uhanova

Received08 Sept 2019

Revised12 Feb 2020

Accepted25 Feb 2020

Published09 Apr 2020

Abstract

Objective. This study aimed to detect 5 kinds of genes related to plasmid-mediated quinolone resistance in four species of nonfermenting bacteria with 2 drug resistance phenotypes (multidrug resistance and pandrug resistance), which were Acinetobacter baumannii (Ab), Pseudomonas aeruginosa (Pa), Stenotrophomonas maltophilia (Sm), and Elizabethkingia meningoseptica (Em). Methods. The Phoenix NMIC/ID-109 panel and API 20NE panel were applied to 19 isolated strains, including 6 Ab strains (2 strains with multidrug resistance and 4 strains with pandrug resistance), 6 Pa strains (3 strains with multidrug resistance and 3 strains with pandrug resistance), 4 Sm strains (2 strains with multidrug resistance and 2 strains with pandrug resistance), and 3 Cm strains (2 strains with multidrug resistance and 1 strain with pandrug resistance). After strain identification and drug susceptibility test, PCR was applied to detect 5 genes related to plasmid-mediated quinolone resistance. The genes detected were quinolone resistance A (qnrA), aminoglycoside acetyltransferase ciprofloxacin resistance variant, acc(6′)-Ib-cr, and 3 integrons (intI1, intI2, and intI3). The amplified products were analyzed by 1% agarose gel electrophoresis and sequenced. Sequence alignment was carried out using the bioinformatics technique. Results. Of 19 strains tested, 8 strains carried acc(6′)-Ib-cr and 6 of them were of pandrug resistance phenotype (3 Ab strains, 2 Pa strains, and 1 Sm strain). The carrying rate of acc(6′)-Ib-cr was 60.0% for strains of pandrug resistance (6/10). Two strains were of multidrug resistance (1 Ab strain and 1 Pa strain), and the carrying rate of acc(6′)-Ib-cr was 22.0% (2/9). The carrying rate was significantly different between strains of multidrug resistance and pandrug resistance (). The class 1 integron was detected in 11 strains, among which 6 strains were of pandrug resistance (3 Ab strains, 2 Pa strains, and 1 Sm strain). The carrying rate of the class 1 integron was 60.0% (6/10). Five strains were of multidrug resistance (3 Pa strains, 1 Ab strain, and 1 Em strain), and the carrying rate was 55.6% (5/9). The carrying rate of the class 1 integron was not significantly different between strains of multidrug resistance and pandrug resistance (). Both acc(6′)-Ib-cr and intI1 were detected in 6 strains, which were negative for qnrA, intI2, and intI3. Conclusion. Quinolone resistance of isolated strains was related to acc(6′)-Ib-cr and intI1 but not to qnrA, intI2, or intI3. The carrying rate of acc(6′)-Ib-cr among the strains of pandrug resistance was much higher than that among the strains of multidrug resistance. But, the strains of two drug resistant phenotypes were not significantly different in the carrying rate of intI1. The detection rates of the two genes were high and similar in Ab and Pa strains. 1 Em strain carried the class 1 integron.

1. Introduction

Acinetobacter baumannii (Ab), Pseudomonas aeruginosa (Pa), and Stenotrophomonas maltophilia (Sm) are common nonfermenting bacteria in clinic [1–3], while Elizabethkingia meningoseptica (Em) is relatively rare [4]. Mutations in these bacteria are largely attributed to overuse and misuse of antibiotics, and drug resistance of these bacteria has become a crisis [5]. Many studies are devoted to the mechanism of quinolone resistance in Ab, Pa, and Sm, but only a few studies are published regarding quinolone resistance in Cm or genes related to plasmid-mediated quinolone resistance and their relationship with different drug resistance phenotypes [6–9]. We detected 5 genes related to plasmid-mediated quinolone resistance in 19 isolated strains (2 Ab strains with multidrug resistance, 4 Ab strains with pandrug resistance, 3 Pa strains with multidrug resistance, 3 Pa strains with pandrug resistance, 2 Sm strains with multidrug resistance, 2 Sm strains with pandrug resistance, 2 Cm strains with multidrug resistance, and 1 Cm strain with pandrug resistance). The genes detected were quinolone resistance A (qnrA), aminoglycoside acetyltransferase ciprofloxacin resistance variant, acc(6′)-Ib-cr, and 3 kinds of integrons (intI1, intI2, and intI3) by using PCR with homology analysis. The purpose of this study was to understand the mechanism of quinolone resistance and its relationship with drug resistance phenotype in clinical strains of Ab, Pa, Sm, and Em.

2. Materials and Methods

2.1. Strains

All 19 strains (2 Ab strains with multidrug resistance, 4 Ab strains with pandrug resistance, 3 Pa strains with multidrug resistance, 3 Pa strains with pandrug resistance, 4 Sm strains, and 3 Cm strains) were clinically isolated and preserved at our hospital. Strain No., identification code, and time of isolation are shown in Table 1.

2.2. Reagents

Phoenix NMIC/ID-109 panel (BD Corporation, BD), M-H agar medium (Oxoid, UK), and API 20NE panel/PSE5.0 susceptibility strip (bioMérieux, France) were used.

2.3. Strain Identification

Bacterial culture was prepared conventionally. The colonies were purified and subjected to the O/F test and oxidase test. The above procedures were performed using a Phoenix NMIC/ID-109 panel, API 20NE panel, and PSE5.0 susceptibility strip.

2.4. Drug Susceptibility Test

MIC was performed using an API 20NE panel, PSE5.0 susceptibility strip, and/or Phoenix NMIC/ID-109 panel according to NCCLS guidelines [10]. For quality control, Pa strain ATCC27853 was used to test the reagents every week.

2.5. Detection of Genes Related to Plasmid-mediated Quinolone Resistance

PCR was applied to 5 genes related to plasmid-mediated quinolone resistance (acc(6′)-Ib-cr, qnrA, and 3 integrons (intI1, intI2, and intI3). The primer sequences and PCR procedures were described in the literature [11]. The amplified products were analyzed by 1% agarose gel electrophoresis.

2.6. Sequencing and Alignment

The amplified genes were purified and sequenced. Homologous sequences were searched using BLAST program in GenBank. The accession number of homologous sequence for acc(6′)-Ib-cr was EF375621.

3. Results

3.1. Drug Resistance

All 19 strains were tested by MICs for drug susceptibility using the Phoenix NMIC/ID-109 panel and PSE5.0 susceptibility strip. Ten strains were of pandrug resistance phenotype and 9 strains were of multidrug resistance phenotype (Table 1).

3.2. Carrying Rates of 5 Detected Genes in Two Drug Resistance Phenotypes

Of 19 strains detected by PCR, 8 strains carried acc(6′)-Ib-cr and 6 of them were of pandrug resistance phenotype (3 Ab strains, 2 Pa strains, and 1 Sm strain). The carrying rate of acc(6′)-Ib-cr was 60.0% for strains of pandrug resistance (6/10). Two strains were of multidrug resistance (1 Ab strain and 1 Pa strain), and they were only negative in the ciprofloxacin susceptibility test. The carrying rate of acc(6′)-Ib-cr was 22.0% (2/9). The carrying rate was significantly different between strains of multidrug resistance and pandrug resistance (). The class 1 integron was detected in 11 strains, among which 6 strains were of pandrug resistance (3 Ab strains, 2 Pa strains, and 1 Sm strain). The carrying rate of the class 1 integron was 60.0% (6/10). Five strains were of multidrug resistance (3 Pa strains, 1 Ab strain, and 1 Cm strain), and they were only negative in the ciprofloxacin susceptibility test. The carrying rate was 55.6% (5/9). The carrying rate of the class 1 integron was not significantly different between strains of multidrug resistance and pandrug resistance (). Both acc(6′)-Ib-cr and intI1 were detected in 6 strains, which were of pandrug resistance (3 Ab strains, 1 Pa strain, and 2 multidrug resistance strains). Five strains were found to carry only intI1, and 2 strains were found to carry only acc(6′)-Ib-cr. They were negative for qnrA, intI2, and intI3 (Table 1, Figures 1 and 2).

3.3. Distribution of Drug Resistance-Related Genes in 4 Bacterial Species

Of 6 Ab strains, 4 strains carried both acc(6′)-Ib-cr and intI1 (3 strains with pandrug resistance and 1 strain with multidrug resistance) and none carried only one drug resistance gene. Of 6 Pa strains, 3 strains carried acc(6′)-Ib-cr, 5 strains intI1, and 2 strains both two genes. No. 5 Sm strain was positive for acc(6′)-Ib-cr, and No. 7 Sm strain was positive for intI1. No. 19 Cm strain, which was of multidrug resistance, carried intI1. Other Cm strains were negative for intI1 and positive for qnrA, intI2, and intI3.

3.4. Homology Analysis

The amplified product of acc(6′)-Ib-cr was sequenced, and it contained 519 nucleic acids. By alignment with sequence (accession number EF375621) in GenBank, the identity was above 99% without sense mutation. This sequence was verified as acc(6′)-Ib-cr. The accession number of acc(6′)-Ib-cr from No. 5 Sm strain was EF210035. DNA and amino acid sequence alignment was two acc(6′)-Ib sequences (AY866525 and EU090799) and one acc(6′)-Ib-cr sequence (EF375621) (Figure 3).

4. Discussion

Chromosomally mediated mechanisms mainly underlie quinolone resistance, such as change of the target site induced by drugs, decreased permeability of outer membrane porin, and active pumping of efflux pump [12]. Drug resistance in Pa may be mediated by plasmids (involving 4 genes, qnr (protection protein), qepA, oqxAB (efflux pump), and acc(6′)-Ib-cr (quinolone-modifying enzyme)) [8]. As the issue of drug resistance is intensifying, the pandrug resistance phenotype has emerged [5]. Genes related to plasmid-mediated quinolone resistance may be engaged in dissemination of genes related to drug resistance mediated by other plasmids [6–9]. Therefore, different genes are involved in quinolone resistance for different drug resistance phenotypes (multidrug or pandrug resistance).

qnrA belongs to the qnr families that protect DNA gyrase from quinolones; qnrB and qnrA are the main genes related to plasmid-mediated quinolone resistance carried by bacteria [6]. However, qnrA was not detected in any of the 19 strains, suggesting that this gene was not related to quinolone resistance in the 4 species of strains tested. Touati et al. [13] and Güler and Eraç [14] also reported that qnr is not the main mechanism of quinolone resistance in Ab strains.

acc(6′)-Ib-cr participates in plasmid-mediated quinolone resistance, encoding for the acc(6′)-Ib enzyme that leads to resistance to norfloxacin and ciprofloxacin [6–9]. Of 19 strains tested, 8 genes carried this gene and 6 of them showed pandrug resistance phenotype. The remaining 2 strains were of multidrug resistance phenotype, and they were only negative in the ciprofloxacin susceptibility test. This means acc(6′)-Ib-cr is involved in the quinolone resistance of Ab, Pa, Sm, and Cm. The carrying rate of this gene was higher for the pandrug resistance phenotype than for the multidrug resistance phenotype. The detection rate of acc(6′)-Ib-cr was higher and similar in Ab and Pa strains.

Integrons are associated with plasmid-mediated quinolone resistance, and class 1, 2, and 3 integrons are the most common, the genetic markers being intI1, intI2, and intI3, respectively. Of 19 strains, intI1 was detected in 11 strains in all species of Ab, Pa, Sm, and Em, among which 6 strains were of pandrug resistance phenotype and 5 strains of multidrug resistance phenotype. Thus, the class 1 integron was related to intI1, but no significant difference was found in the carrying rate between the pandrug resistance phenotype and multidrug resistance phenotype (). Class 2 and 3 integrons were not detected in any of the strains, which agreed with previous reports [15–18]. Therefore, class 2 and 3 integrons were not related to quinolone resistance in the tested strains. intI1 had a high and similar detection rate in Ab and Pa strains. Few reports were on the class 1 integron in EM [19, 20]; in this paper, 1 Em strain carried the class 1 integron.

Both acc(6′)-Ib-cr and intI1 were detected in 6 strains (4 pandrug resistance strains (3 Ab strains and 1 Pa strain) and 2 multidrug resistance strains). Five strains carried only intI1, and 2 strains carried only acc(6′)-Ib-cr. The strains carrying both acc(6′)-Ib-cr and intI1 mostly belonged to pandrug resistance phenotype. Moreover, it is proved that acc(6′)-Ib-cr exists in intI1 [6–9].

To conclude, the mechanism of plasmid-mediated quinolone resistance is mainly related to acc(6′)-Ib-cr and intI1, which have high and similar detection rates in Ab and Pa strains, but not to qnrA, intI2, or intI3. The carrying rate of acc(6′)-Ib-cr was higher in the pandrug resistance phenotype than in the multidrug resistance phenotype. However, the two phenotypes did not differ significantly in the carrying rate of intI1, and acc(6′)-Ib-cr exists in intI1. 1 Em strain carried the class 1 integron. Also, further studies are needed to investigate the resistance mechanisms, ESBLs, MBLs, OXA-type carbapenemases, and aminoglycoside resistance determinants in the 19 strains.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

This work was supported by the Fujian Province Science and Technology Planning Foundations (2015J01514) and the Quanzhou High Level Talent Innovation and Entrepreneurship Project (2017Z36).

References

R. C. Dantas, M. L. Ferreira, P. P. Gontijo-Filho, and R. M. Ribas, “Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome,” Journal of Medical Microbiology, vol. 63, no. 12, pp. 1679–1687, 2014.
View at: Publisher Site | Google Scholar
H.-z. Zhang, J. S. Zhang, and L. Qiao, “The Acinetobacter baumannii group: a systemic review,” World Journal of Emergency Medicine, vol. 4, no. 3, pp. 169–174, 2013.
View at: Publisher Site | Google Scholar
C. J. Pien, H. Y. Kuo et al., “Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital,” Journal of Microbiology, Immunology and Infection, vol. 48, pp. 291–295, 2013.
View at: Publisher Site | Google Scholar
M.-S. Hsu, C.-H. Liao et al., “Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999–2006,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 30, no. 10, pp. 1271–1278, 2011.
View at: Publisher Site | Google Scholar
I. Karaiskos and H. Giamarellou, “Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches,” Expert Opinion on Pharmacotherapy, vol. 15, no. 10, pp. 1351–1370, 2014.
View at: Publisher Site | Google Scholar
L. Poirel, V. Cattoir, and P. Nordmann, “Plasmid-Mediated quinolone resistance; Interactions between human, animal, and environmental ecologies,” Frontiers in Microbiology, vol. 3, p. 24, 2012.
View at: Publisher Site | Google Scholar
J. Ruiz, M. J. Pons, and C. Gomes, “Transferable mechanisms of quinolone resistance,” International Journal of Antimicrobial Agents, vol. 40, no. 3, pp. 196–203, 2012.
View at: Publisher Site | Google Scholar
V. Cattoir and P. Nordmann, “Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update,” Current Medicinal Chemistry, vol. 16, no. 8, pp. 1028–1046, 2009.
View at: Publisher Site | Google Scholar
J. M. Rodríguez-Martínez, C. Velasco et al., “Plasmid-mediated quinolone resistance: an update,” Journal of Infection and Chemotherapy, vol. 17, no. 2, pp. 149–182, 2011.
View at: Publisher Site | Google Scholar
Clinical and Laboratory Standards Institute, Performance Standardsfor Antimicrobial Susceptibility Testing: Twenty-Sixth Informational SupplementM100-S26, CLSI, Wayne, PA, USA, 2016.
H. Yang, H. Chen, Q. Yang, M. Chen, and H. Wang, “High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6′)-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 12, pp. 4268–4273, 2008.
View at: Publisher Site | Google Scholar
A. Fàbrega, S. Madurga, E. Giralt, and J. Vila, “Mechanism of action of and resistance to quinolones,” Microbial Biotechnology, vol. 2, no. 1, pp. 40–61, 2009.
View at: Publisher Site | Google Scholar
A. Touati, L. Brasme, S. Benallaoua, A. Gharout, J. Madoux, and C. De Champs, “First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals,” Diagnostic Microbiology and Infectious Disease, vol. 60, no. 3, pp. 287–290, 2008.
View at: Publisher Site | Google Scholar
G. Güler and B. Eraç, “Investigation of fluoroquinolone resistance mechanisms in clinical Acinetobacter baumannii isolates,” Mikrobiyoloji Bulteni, vol. 50, no. 2, pp. 278–286, 2016.
View at: Publisher Site | Google Scholar
C. Huang, Q. Long et al., “Resistance and integron characterization of Acinetobacter baumannii in a teaching hospital in Chongqing, China,” New Microbes and New Infections, vol. 8, pp. 103–108, 2015.
View at: Publisher Site | Google Scholar
J. Chen, H. Li, J. Yang, R. Zhan, A. Chen, and Y. Yan, “Prevalence and characterization of integrons in multidrug resistant acinetobacter baumannii in Eastern China: amultiple-hospital study,” International Journal of Environmental Research and Public Health, vol. 12, no. 8, pp. 10093–10105, 2015.
View at: Publisher Site | Google Scholar
M. Bagheri-Nesami, M. S. Rezai et al., “Multidrug and co-resistance patterns of non-fermenting Gram-negative bacilli involved in ventilator-associated pneumonia carrying class 1 integron in the North of Iran,” Germs, vol. 7, no. 3, pp. 123–131, 2017.
View at: Publisher Site | Google Scholar
E. Usta, C. Eroğlu, K. Yanik, A. Karadağ, A. K. Güney, and M. Günaydin, “Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates,” Mikrobiyoloji Bulteni, vol. 49, no. 1, pp. 35–46, 2015.
View at: Publisher Site | Google Scholar
T. Cimmino and J.-M. Rolain, “Whole genome sequencing for deciphering the resistome of Chryseobacterium indologenes, an emerging multidrug-resistant bacterium isolated from a cystic fibrosis patient in Marseille, France,” New Microbes and New Infections, vol. 12, pp. 35–42, 2016.
View at: Publisher Site | Google Scholar
E. J. Dziuban, J. L. Franks, M. So, G. Peacock, and D. D. Blaney, “Elizabethkingia in children: acomprehensive review of symptomatic cases reported from 1944 to 2017,” Clinical Infectious Diseases, vol. 67, no. 1, pp. 144–149, 2017.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2020 De-Song Ming et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

493

Downloads

1035

Citations